Nörolojik Bakış Açısından COVID-19

Yıl: 2020 Cilt: 26 Sayı: 2 Sayfa Aralığı: 58 - 108 Metin Dili: Türkçe DOI: 10.4274/tnd.2020.73669 İndeks Tarihi: 18-07-2022

Nörolojik Bakış Açısından COVID-19

Öz:
-
Anahtar Kelime:

The COVID-19 from Neurological Overview

Öz:
-
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
0
0
0
  • 1. T.C. Sağlık Bakanlığı. 14.4.2020. Available from: https://www.tjod.org/wpcontent/ uploads/2020/04/COVID-19_Rehberi-14.04.2020.pdf
  • 2. Kilic AU, Kara F, Alp E, Doganay M. New threat: 2019 novel Coronavirus infection and infection control perspective in Turkey. North Clin Istanb. 2020;7:95-98.
  • 3. Killerby ME, Biggs HM, Haynes A, et al. Human coronavirus circulation in the United States 2014-2017. J Clin Virol. 2018;101:52-56.
  • 4. Akin L, Gözel MG. Understanding dynamics of pandemics. Turk J Med Sci. 2020;50(SI-1):515-519.
  • 5. Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Transmission. Emerg Infect Dis 2020;26:191-198.
  • 6. Swerdlow DL, Finelli L. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics. JAMA 2020;323:1129-1130.
  • 7. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. Treasure Island (FL); 2020.
  • 8. Şeker M, Özer A, Tosun Z, Korkut C, Doğrul M. TUBA-COVID-19 Pandemi Değerlendirme Raporu; 2020.
  • 9. Qian X, Ren R, Wang Y, et al. Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind. Infect Dis Poverty 2020;9:34.
  • 10. Wikipedia. Türkiye’de 2020 koronavirüs pandemisi. 2020. Available from: https:// tr.wikipedia.org/wiki/T%C3%BCrkiye%27de_COVID-19_ pandemisi
  • 11. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. 2019-Ncov Hastalığı: Sağlık Çalışanları Rehberi. Yayın-Ocak-2020-Ulaşım 4.5.2020.
  • 12. WorldoMeter. COVID-19 Coronavirus Pandemic. 2020.
  • 13. Oksanen A, Kaakinen M, Latikka R, Savolainen I, Savela N, Koivula A. Regulation and Trust: 3-Month Follow-up Study on COVID-19 Mortality in 25 European Countries. JMIR Public Health Surveill. 2020;6:e19218.
  • 14. Kamps B, Hoffmann C. COVID References Eng2020-3. Third edition 2020-3 uploaded on 23 April 2020.
  • 15. UN-Department-of-Economic-and-Social-Affairs-Social-Inclusion. 2020. The Social Impact of COVID-19.
  • 16. Acikgoz O, Gunay A. The early impact of the COVID-19 pandemic on the global and Turkish economy. Turk J Med Sci 2020;50:520-526.
  • 17. Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 2003;362:1353-1358.
  • 18. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-1820.
  • 19. Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Vuhan, China: potential for international spread via commercial air travel. J Travel Med 2020;27.
  • 20. World Health Organization (WHO). Novel Corona virüs-China Disease outbreak news: Update 12 January 2020.
  • 21. Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-544.
  • 22. World Health Organization (WHO). Director-General’s remarks at the media briefing on 2019 nCoV on 11 February 2020.
  • 23. World Health Organization (WHO). General’s opening remarks at the media briefing on COVID-19 - 11 March 2020.
  • 24. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015;1282:1-23.
  • 25. Masters PS. The molecular biology of coronaviruses. Adv Virüs Res 2006;66:193-292.
  • 26. Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol 2016;3:237-261.
  • 27. Wertheim JO, Chu DK, Peiris JS, Kosakovsky Pond SL, Poon LL. A case for the ancient origin of coronaviruses. J Virol 2013;87:7039-7045.
  • 28. Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Virüses 2012;4:3044-3068.
  • 29. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-192.
  • 30. Woo PC, Yuen KY, Lau SK. Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study. Hong Kong Med J 2012;18 Suppl 2:22-24.
  • 31. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARSCoV- 2 and Coronavirus Disease 2019: What We Know So Far. Pathogens 2020;9.
  • 32. Forni D, Cagliani R, Clerici M, Sironi M. Molecular Evolution of Human Coronavirus Genomes. Trends Microbiol 2017;25:35-48.
  • 33. Zhou P, Fan H, Lan T, et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 2018;556:255- 258.
  • 34. Fan Y, Zhao K, Shi ZL, Zhou P. Bat Coronaviruses in China. Virüses 2019;11:210.
  • 35. Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med 2020;28:174-184.
  • 36. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-733.
  • 37. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020;26:450-452.
  • 38. Feyzioğlu B. SARS-CoV-2 Kökeni. J Biotechnol and Strategic Health Res 2020;Ozel sayi:1-9.
  • 39. World-Health-Organization (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. 2020.
  • 40. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review. Anaesthesia 2020.
  • 41. Wang H, Li X, Yan Z, Sun X, Han J, Zhang B. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 2020;13:1-2.
  • 42. Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020;382:1564-1567.
  • 43. World Health Organization (WHO). Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) 2020.
  • 44. World Health Organization (WHO). Telemedicine in Member States: Opportunities and developments. Report on the second global survey on eHealth. Global Observatory for eHealth series-Volume 2, 2010.
  • 45. Kim JM, Chung YS, Jo HJ, et al. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health Res Perspect 2020;11:3-7.
  • 46. Balazy A, Toivola M, Adhikari A, Sivasubramani SK, Reponen T, Grinshpun SA. Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? Am J Infect Control 2006;34:51-57.
  • 47. Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J 1998;59:128-132.
  • 48. Beckman S, Materna B, Goldmacher S, et al. Evaluation of respiratory protection programs and practices in California hospitals during the 2009- 2010 H1N1 influenza pandemic. Am J Infect Control 2013;41:1024-1031.
  • 49. T.C. Sağlık Bakanlığı. Covıd-19 Hastalığına Yönelik Sağlık Kuruluşu, Personel Ve Faaliyet Türüne Göre Kullanılması Önerilen Koruyucu Ekipmanlar.
  • 50. PHAC-the-Public-Health-Agency-of-Canada. Community-based measures to mitigate the spread of coronavirus disease (COVID-19) in Canada. 2020.
  • 51. Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020.
  • 52. Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19). From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020.
  • 53. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-1720.
  • 54. Jin H HC, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists Stroke & Vascular Neurology 2020.
  • 55. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020;382:970- 971. 56. Lan L, Xu D, Ye G, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020.
  • 57. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020;9:687-690.
  • 58. To KF, Tong JH, Chan PK, et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol 2004;202:157-163.
  • 59. Ozturk S. COVID-19 ve Nöroloji. Turk J Neurol 2020. DOI:10.4274/tnd. galenos.2020.73384
  • 60. Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Vuhan, China: a retrospective case series study. medRxiv 2020.
  • 61. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Vuhan, China. JAMA 2020;323:1061-1069.
  • 62. Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, Yuen KY. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004;10:342-344.
  • 63. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55-58.
  • 64. Baig AM. Neurological manifestations in COVID-19 caused by SARSCoV- 2. CNS Neurosci Ther 2020;26:499-501.
  • 65. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID- 19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology 2020;296:E119-E120.
  • 66. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 2020.
  • 67. Alberti P, Beretta S, Piatti M, et al. Guillain-Barre syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 2020;7:e741.
  • 68. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020;176:516-518.
  • 69. Virani A, Rabold E, Hanson T, et al. Guillain-Barre Syndrome associated with SARS-CoV-2 infection. IDCases 2020:e00771.
  • 70. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383-384.
  • 71. Gutierrez-Ortiz C, Mendez A, Rodrigo-Rey S, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 2020. DOI: 10.1212/ WNL.0000000000009619
  • 72. Zhao K HJ, Dai D, Feng Y, Liu L, Nie S. Acute Myelitis After SARS-CoV-2 Infection: A Case Report. medRxiv 2020;2020:20035105.
  • 73. Wei H, Yin H, Huang M, Guo Z. The 2019 novel cornoavirüs pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol 2020;267:1550- 1553.
  • 74. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020:1239-1242.
  • 75. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;46:837-840.
  • 76. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med 2020;35:1545-1549.
  • 77. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091.
  • 78. Duffin J. Functional organization of respiratory neurones: a brief review of current questions and speculations. Exp Physiol 2004;89:517-529.
  • 79. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552-555.
  • 80. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA 2020;323:1488-1494.
  • 81. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Vuhan, China. Lancet 2020;395:497-506.
  • 82. Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020:200463. DOI: 10.1148/radiol.2020200463
  • 83. Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology 2020;296:E113-E114.
  • 84. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020;109:102433.
  • 85. Feng Y, Ling Y, Bai T, et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med 2020;201:1380-1388.
  • 86. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Vuhan, China: a descriptive study. Lancet Infect Dis 2020;20:425-434.
  • 87. Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 2020;55:2000524.
  • 88. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology 2020;295:715-721.
  • 89. Fan N, Fan W, Li Z, Shi M, Liang Y. Imaging characteristics of initial chest computed tomography and clinical manifestations of patients with COVID-19 pneumonia. Jpn J Radiol 2020;38:533-538.
  • 90. Liu C, Wu C, Zheng X, et al. Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases. J Formos Med Assoc 2020;S0929-6646(20)30144-3.
  • 91. World Health Organization (WHO). Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance. 2020.
  • 92. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol 2020;75:2352-2371.
  • 93. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Vuhan, China: a descriptive study. Lancet 2020;395:507-513.
  • 94. Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69:1002-1009.
  • 95. Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020;69:997-1001.
  • 96. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology 2020;158:1831-1833.
  • 97. Ong J, Young BE, Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut 2020;69:1144-1145.
  • 98. International MG/COVID-19 Working Group, Jacob S, Muppidi S, et al. Guidance for the management of myasthenia gravis (MG) and Lambert- Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020;412:116803.
  • 99. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology 2020;158:1518-1519.
  • 100. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020;382:929-936.
  • 101. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606.
  • 102. Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol 2020;8:18-24.
  • 103. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420- 422.
  • 104. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020;ciaa248. DOI:10.1093/cid/ciaa248
  • 105. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020;180:1-11.
  • 106. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020;95:834-847.
  • 107. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-147.
  • 108. Spiezia L, Boscolo A, Poletto F, et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost 2020;120:998-1000.
  • 109. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020;506:145-148.
  • 110. Keyaerts E, Li S, Vijgen L, et al. Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 2009;53:3416-3421.
  • 111. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020;57:279-283.
  • 112. US Food and Drug Administration (FDA). 2020. Available from: https:// www.fda.gov/media/136534/download
  • 113. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis DOI:10.1093/cid/ciaa478
  • 114. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents DOI:10.1016/j.ijantimicag.2020.105949
  • 115. Cai Q, Yang M, Liu D, et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study Engineering (Beijing) DOI:10.1016/j.eng.2020.03.007
  • 116. Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 2020;20:697-706.
  • 117. Cao YC, Deng QX, Dai SX. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Med Infect Dis 2020;35:101647.
  • 118. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020;382:1787-1799. 119. Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci 2020;248:117477.
  • 120. T.C. Sağlık B akanlığı Sağlık Hizmetleri Genel Müdürlüğü. COVID-19 İmmün (Konvalesan) Plazma Tedarik Ve Klinik Kullanım Rehber. 2020. Available from: https:// dosyamerkez.saglik.gov.tr/Eklenti/37320,covid- 19-immun- plazma-tedarik-ve-klinik-kullanim-rehberi-r1-v1pdf.pdf?0&_ tag1=F8E6A66A629175DA4A99810BDF399C485F1A9375
  • 121. Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. EBioMedicine 2020;55:102743.
  • 122. Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19?. Allergy 2020;75:1824-1827.
  • 123. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv 2020. doi: https://doi.org/10.1101/2020.03.24.20042937
  • 124. Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8:506-517.
  • 125. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA 2020. doi:10.1001/jama.2020.3633
  • 126. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-887.
  • 127. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296:E32-E40.
  • 128. Dong X, Cao YY, Lu XX, et al. Eleven faces of coronavirus disease 2019. Allergy 2020;75:1699-1709.
  • 129. Halacli B, Kaya A, Topeli A. Critically-ill COVID-19 patient. Turk J Med Sci 2020;50(Suppl 1)585-591.
  • 130. Soldati G, Smargiassi A, Inchingolo R, et al. Is There a Role for Lung Ultrasound During the COVID-19 Pandemic?. J Ultrasound Med 2020;39:1459-1462.
  • 131. Li L, Li R, Wu Z, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care 2020;10:45.
  • 132. Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother 2020;75:1667-1670.
  • 133. Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020.
  • 134. Borba MGS, Val FFA, Sampaio VS, et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Netw Open 2020;3:e208857.
  • 135. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020;14:58-60.
  • 136. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-1034.
  • 137. Wang Y, Jiang W, He Q, et al. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther 2020;5:57.
  • 138. Werdan K, Pilz G, Bujdoso O, et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 2007;35:2693- 2701.
  • 139. Ni YN, Luo J, Yu H, Liu D, Liang BM, Liang ZA. The effect of highflow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis. Am J Emerg Med 2018;36:226- 233.
  • 140. Respiratory-Therapy-Group. Expert Consensus on Respiratory Therapy Related to New Coronavirus Infection in Severe and Critical Patients Chinese Journal of Tuberculosis and Respiratory Medicine 2020; 17: E020-E.
  • 141. Wu CN, Xia LZ, Li KH, et al. High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial. Br J Anaesth 2020;125:e166-e168.
  • 142. Wahidi MM, Lamb C, Murgu S, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol 2020. doi:10.1097/LBR.0000000000000681
  • 143. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099-1102.
  • 144. Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care 2020;24:154.
  • 145. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020;201:1299-1300.
  • 146. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-260.
  • 147. Muscogiuri G, Barrea L, Savastano S, Colao A. Nutritional recommendations for CoVID-19 quarantine. Eur J Clin Nutr 2020;74:850-851.
  • 148. Joob B, Wiwanitkit V. COVID-19, School Closings, and Weight Gain. Obesity (Silver Spring) 2020;28:1006.
  • 149. Dunn CG, Kenney E, Fleischhacker SE, Bleich SN. Feeding Low-Income Children during the Covid-19 Pandemic. N Engl J Med 2020;382:e40.
  • 150. Barazzoni R, Bischoff SC, Breda J, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARSCoV- 2 infection. Clin Nutr 2020;39:1631-1638.
  • 151. Reyes L, Arvelo W, Estevez A, et al. Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009. Influenza Other Respir Viruses 2020;4:129-140.
  • 152. Calder PC. Feeding the immune system. Proc Nutr Soc 2013;72:299-309.
  • 153. World Health Organization (WHO). 2020. Available from: http://www. emro.who.int/nutrition/nutrition-infocus/nutrition-advice-for-adultsduring- the-covid-19-outbreak.html
  • 154. Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr 2018;37:336- 353.
  • 155. Caccialanza R, Laviano A, Lobascio F, et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition 2020;74:110835.
  • 156. Reeves A, White H, Sosnowski K, Tran K, Jones M, Palmer M. Energy and protein intakes of hospitalised patients with acute respiratory failure receiving non-invasive ventilation. Clin Nutr 2014;33:1068-1073.
  • 157. Leder SB, Siner JM, Bizzarro MJ, McGinley BM, Lefton-Greif MA. Oral Alimentation in Neonatal and Adult Populations Requiring High-Flow Oxygen via Nasal Cannula. Dysphagia 2016;31:154-159.
  • 158. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019;38:48-79.
  • 159. Bertran Recasens B, Martinez-Llorens JM, Rodriguez-Sevilla JJ, Rubio MA. Lack of dyspnea in patients with Covid-19: another neurological conundrum? Eur J Neurol 2020. DOI:10.1111/ene.14265
  • 160. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARSCoV- 2 Infection. N Engl J Med 2020;382:2268-2270.
  • 161. Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol 2020. DOI:10.1111/ene.14277
  • 162. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barre Syndrome Associated with SARS-CoV-2. N Engl J Med 2020;382:2574-2576.
  • 163. Yin R, Feng W, Wang T, et al. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019. J Med Virol 2020. doi:10.1002/jmv.25888
  • 164. National Health Commission tate Administration of Traditional Chinese Medicine. Diagnosis and treatment of COVID-19 (trial version 6). 2020.
  • Available from: http://en.nhc.gov.cn/search.html?searchText=Diagnosis+an d+treatment+of+COVID-19+%28trial+version+6%29
  • 165. Shellhaas RA. Neurologists and COVID-19: A note on courage in a time of uncertainty. Neurology 2020;94:855-857.
  • 166. American Clinical Neurophysiology Society. COVID-19 Resources. 2020. Available from: https://www.acns.org/practice/covid-19-resources
  • 167. Haines S, Caccamo A, Chan F, Gupta P. Practical Considerations When Performing Neurodiagnostic Studies on Patients with COVID-19 and Other Highly Contagious Diseases. Available from: https://www.acns. org/UserFiles/file/ASET_PracticalConsiderationsWhenPerforming NeurodiagnosticStudiesonPatientswithCOVID.pdf
  • 168. Müller KI, Alstadhaug KB, Bekkelund SI. Telemedicine in the management of non-acute headaches: A prospective, open-labelled non-inferiority, randomised clinical trial. Cephalalgia 2017;37:855-863.
  • 169. Westover MB, Gururangan K, Markert MS, et al. Diagnostic Value of Electroencephalography with Ten Electrodes in Critically Ill Patients. Neurocrit Care 2020. doi:10.1007/s12028-019-00911-4
  • 170. American Association of Neuromuscular Electrodiagnostic Medicine (AANEM). 2020. Available from: https://www.aanem.org/ getmedia/88faf677-8043-4ad3-ad0d-42c0cdd1dabe/Guidance-for-EMGstudies- during-COVIDpdf
  • 171. Hacettepe Üniversitesi Tıp-Fakültesi Nöroloji AD EMG Birimi. Hacettepe Pandemi Döneminde EMG Laboratuvarında Çalışma Kılavuzu. 2020. Available from: https://www.noroloji.org.tr/TNDData/Uploads/files/ hacettepe%20emg.pdf
  • 172. Kocasoy Orhan E. İstanbul Üniversitesi İstanbul Tıp Fakültesi Nöroloji Anabilim Dalı Elektromiyografi Laboratuvarı’nda kullanılan “Pandemide EMG İncelemesi Sırasında Dikkat Edilmesi Gereken Adımlar”. 2020. Available from: https://www.noroloji.org.tr/TNDData/Uploads/files/ PANDEM%C4%B0DE%20EMG%20KURALLARI(1).docx
  • 173. Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020;582:557-560.
  • 174. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77:1-9.
  • 175. Liu K, Pan M, Xiao Z, Xu X. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020. J Neurol Neurosurg Psychiatry 2020;91:669-670.
  • 176. Zhou B, She J, Wang Y, Ma X. A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis. Front Neurol 2020;11:296.
  • 177. Rossi A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008;18:149-161.
  • 178. Wong AM, Simon EM, Zimmerman RA, Wang HS, Toh CH, Ng SH. Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006;27:1919- 1923.
  • 179. Li Y, Wang M, Zhou Y, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. SSRN Electronic Journal 2020.
  • 180. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect 2020;35:100669.
  • 181. Birbeck GL, French JA, Perucca E, et al. Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia 2012;53:207-214.
  • 182. Zhang T, Rodricks MB, Hirsh E. COVID-19-Associated Acute Disseminated Encephalomyelitis: A Case Report. medRxiv 2020.
  • 183. Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol 2020. DOI:10.1002/jmv.25884
  • 184. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med 2020;9.
  • 185. Collaborators GBDH. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17:954-976.
  • 186. Science alert. Updated: WHO Now Doesn’t Recommend Avoiding Ibuprofen For COVID-19 Symptoms. Available from: https://www. sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid- 19-symptoms
  • 187. FDA. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. 2020. Available from: https://www.fda.gov/ drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidalanti- inflammatory-drugs-nsaids-covid-19
  • 188. Centers for Disease Control and Prevention (CDC). 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidancemanagement- patients.html
  • 189. Halker RB, Starling AJ, Vargas BB, Schwedt TJ. ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They? Curr Treat Options Neurol 2016;18:15.
  • 190. Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail 2020;26:370.
  • 191. Szperka CL, Ailani J, Barmherzig R, et al. Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers. Headache 2020;60:833- 842.
  • 192. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;S0889- 1591.
  • 193. British Geriatrics Society European Delirium Association Old Age Psychiatry Faculty (Royal College of Psychiatrists). Coronavirus: Managing delirium in confirmed and suspected cases. BGS 2020 Available from: https://www.bgs.org.uk/resources/coronavirus-managing-delirium-inconfirmed- and-suspected-cases
  • 194. Hoffmann C. Available from: https://amedeo.com/CovidReference02_fr.pdf
  • 195. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020;413:116832.
  • 196. Aktoz M, Altay H, Aslanger E, et al. [Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)]. Turk Kardiyol Dern Ars 2020;48(Suppl 1):1-48.
  • 197. The-Liverpool-Drug-Interaction-Group. Detailed recommendations for interactions with experimental COVID-19 therapies. 2020. https://www. covid19-druginteractions.org/
  • 198. Das G, Mukherjee N, Ghosh S. Neurological Insights of COVID-19 Pandemic. ACS Chem Neurosci 2020;11:1206-1209.
  • 199. Clay PG, Adams MM. Pseudo-Parkinson disease secondary to ritonavirbuspirone interaction. Ann Pharmacother 2003;37:202-205.
  • 200. Kelly DV, Béïque LC, Bowmer MI. Extrapyramidal symptoms with ritonavir/indinavir plus risperidone. Ann Pharmacother 2002;36:827-830.
  • 201. Caparros-Lefebvre D, Lannuzel A, Tiberghien F, Strobel M. Protease inhibitors enhance levodopa effects in Parkinson’s disease. Mov Disord 1999;14:535.
  • 202. Şimşek YS, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci 2020;50(Suppl 1):611-619.
  • 203. Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020;50(Suppl 1):620-632.
  • 204. Hoffmann G, Funk C, Fowler S, et al. Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system. Antimicrob Agents Chemother 2009;53:4753-4761.
  • 205. Gonzalez Martinez A, Romero Palacián D, Dotor García Soto J, Sánchez P, Reig Roselló G, Zapata Wainberg G. Tocilizumab-Associated Reversible Cerebral Vasoconstriction: A Case Report. Headache 2019;59:259-263.
  • 206. Jewell P, Ansorge O, Kuker W, Irani SR, Zamboni G. Tocilizumabassociated multifocal cerebral thrombotic microangiopathy. Neurol Clin Pract 2016;6:e24-e26.
  • 207. Karimi N, Razavi AS, Rouhani S. Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report. Iran Red Crescent Med J 2020;22:e102828.
  • 208. Han DH, Kim SY, Lee NM, et al. Seasonal distribution of febrile seizure and the relationship with respiratory and enteric viruses in Korean children based on nationwide registry data. Seizure 2019;73:9-13.
  • 209. Holohan M. Nearly a week after COVID-19 diagnosis, 1-year-old is recovering, ‘happy’. Today 2020. https://www.today.com/health/kidscoronavirus- 1-year-old-recovering-after-covid-19-diagnosis-t177203
  • 210. Lu L, Xiong W, Liu D, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia 2020;61:e49-e53.
  • 211. Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014;29:301- 306.
  • 212. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;12:e7352.
  • 213. French JA, Brodie MJ, Caraballo R, et al. Keeping people with epilepsy safe during the Covid-19 pandemic. Neurology 2020;94(23):1032- 1037.
  • 214. T.C. Sağlık Bakanlığı Kamu Hastaneleri Genel Müdürlüğü Tedarik Planlama Stok ve Lojistik Yönetimi Dairesi Başkanlığı. COVID-19 Tedavisinde Kullanılan İlaçlar İlaç Etkileşimleri.
  • 215. Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-1276.
  • 216. Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. Guillain-Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report. SAGE Open Med Case Rep 2019;7:2050313X19838750.
  • 217. Kim JE, Heo JH, Kim HO, et al. Neurological Complications during Treatment of Middle East Respiratory Syndrome. J Clin Neurol 2017;13:227-233.
  • 218. Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? J Neurol 2020;267:1877-1879.
  • 219. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-337. 220. Guidon AC, Amato A. COVID-19 and neuromuscular disorders. Neurology 2020;94:959-969.
  • 221. Rajabally YA, Goedee HS, Attarian S, Hartung HP. Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic. Muscle Nerve 2020;62:34-40.
  • 222. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med 2020;382:1969-1973.
  • 223. Benveniste O, Longuet P, Duval X, Le Moing V, Leport C, Vildé JL. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir. Clin Infect Dis 1999;28:1180-1181.
  • 224. Estes ML, Ewing-Wilson D, Chou SM, et al. Chloroquine neuromyotoxicity. Clinical and pathologic perspective. 1987;82:447-455.
  • 225. Jallouli M, Saadoun D, Eymard B, et al. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol 2012; 259:1290-1297.
  • 226. Gummi RR, Kukulka NA, Deroche CB, Govindarajan R. Factors associated with acute exacerbations of myasthenia gravis. Muscle Nerve 2019; 60:693- 699.
  • 227. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci 2020;76:233-235.
  • 228. Novi G, Mikulska M, Briano F, et al. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Mult Scler Relat Disord 2020;42:102120.
  • 229. Markus HS, Brainin M. COVID-19 and stroke-A global World Stroke Organization perspective. Int J Stroke 2020;15:361-364.
  • 230. Bersano A, Bornstein, N. Stroke Care at the Time of COVID-19 Outbreak. Eanpages 2020. Available from: https://www.eanpages.org/2020/04/17/ stroke-care-at-the-time-of-covid-19-outbreak/
  • 231. Lyden P. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. Stroke 2020.
  • 232. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med 2020;382:e60.
  • 233. Smith EE, Mountain A, Hill MD, et al. Canadian Stroke Best Practice Guidance During the COVID-19 Pandemic. Can J Neurol Sci 2020;47:474- 478.
  • 234. Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected Code Stroke Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. Stroke 2020;51:1891- 1895.
  • 235. Baracchini C, Pieroni A, Viaro F, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci 2020;41:1003-1005.
  • 236. Topçuoğlu M, Arsava EM, Özdemir AÖ. Acute Ischemıc Stroke Treatment in COVID-19 pandemıa: Expert Opinion. Türk Beyin Damar Hast Der 2020;26:91-94.
  • 237. Desai SM, Tonetti DA, Molyneaux BJ, et al. Interaction between time, ASPECTS, and clinical mismatch. J Neurointerv Surg 2020. DOI:10.1136/ neurintsurg-2020-015921
  • 238. Aggour M, White P, Kulcsar Z, Fiehler J, Brouwer P. European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the covid-19 era. J Neurointerv Surg 2020;12:542-544.
  • 239. Fraser JF, Arthur AS, Chen M, et al. Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of covid-19. J Neurointerv Surg 2020;12:539-541.
  • 240. Nguyen TN, Abdalkader M, Jovin TG, et al. Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology. Stroke 2020;51:1896-1901.
  • 241. Dimitrijevic MR. Outline of restorative neurology: definition, clinical practice, assessment, intervention. Clin Neurol Neurosurg 2012;114:428- 431.
  • 242. Bartolo M, Intiso D, Lentino C, et al. Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/ Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic. Front Neurol 2020;11:423.
  • 243. World Health Organization (WHO). 2020. Available from: https:// www.who.int/publications-detail/home-care-for-patients-with-suspectednovel- coronavirus-(ncov)-infection-presenting-with-mild-symptoms-andmanagement- of-contacts
  • 244. Duff WRD, Andrushko JW, Renshaw DW, et al. Impact of Pilates Exercise in Multiple Sclerosis A Randomized Controlled Trial. Int J MS Care 2018;20:92-100.
  • 245. Kalb R, Brown TR, Coote S, et al. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler 2020:1352458520915629.
  • 246. Coronado RA, Albers HE, Allen JL, et al. Pain-Reducing Effects of Physical Therapist-Delivered Interventions: A Systematic Review of Randomized Trials Among Older Adults With Dementia. J Geriatr Phys Ther 2020;43:159-169.
  • 247. Marx KA, Scott JB, Piersol CV, Gitlin LN. Tailored Activities to Reduce Neuropsychiatric Behaviors in Persons With Dementia: Case Report. Am J Occup Ther 2019;73: 7302205160p1-7302205160p9.
  • 248. Hsu TJ, Tsai HT, Hwang AC, Chen LY, Chen LK. Predictors of nonpharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia. Geriatr Gerontol Int 2017;(Suppl 1):28-35.
  • 249. Trabucchi M, De Leo D. Nursing homes or besieged castles: COVID-19 in northern Italy. Lancet Psychiatry 2020;7:387-388.
  • 250. Lee KH, Kim JM, Kim HS. Back Extensor Strengthening Exercise and Backpack Wearing Treatment for Camptocormia in Parkinson’s Disease: A Retrospective Pilot Study. Ann Rehabil Med 2017;41:667-685.
  • 251. Devlin K, Alshaikh JT, Pantelyat A. Music Therapy and Music-Based Interventions for Movement Disorders. Curr Neurol Neurosci Rep 2019;19:83.
  • 252. Gelaw AY, Janakiraman B, Gebremeskel BF, Ravichandran H. Effectiveness of Home-based rehabilitation in improving physical function of persons with Stroke and other physical disability: A systematic review of randomized controlled trials. J Stroke Cerebrovasc Dis 2020;104800.
  • 253. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report - 35. 2020. Available from: https://www.who.int/doc s/ default- ource/coronaviruse/situation-reports/20200224- sitrep-35- covid-19.pdf?sfvrsn=1ac4218d_2
  • 254. CDC. Reducing Stigma 2020. Available from: https://www.cdc.gov/ coronavirus/2019-ncov/daily-life-coping/reducing-stigma.html 255. Devakumar D, Shannon G, Bhopal SS, Abubakar I. Racism and discrimination in COVID-19 responses. Lancet 2020;395:1194.
  • 256. Lum M. Covid-19: Stop the stigma and stereotyping of coronavirus sufferers. 2020. Available from: https://www.thestar.com.my/lifestyle/ health/2020/03/17/fighting-against-the-stigma-of-covid-19
  • 257. World Health Organization (WHO). Managing Ethical Issues in Infectious Disease Outbreaks. 2016. Available from: https://www.who.int/ethics/ publications/infectious-disease-outbreaks/en/
  • 258. NYS Workgroup on Ventilator Allocation in an Influenza Pandemic. Allocation of ventilators in an influenza pandemic: Planning document. New York State Task Force on Life and the Law. 2007. Available from: https:// www.cidrap.umn.edu/sites/default/files/public/php/196/196_guidance.pdf
  • 259. New York State Task Force on Life and the Law. Ventilator allocation guidelines. 2015. Available from: https://www.health.ny.gov/regulations/ task_force/reports_publications/docs/ventilator_guidelines.pdf
  • 260. World Health Organization (WHO). 2020. Available from: https://www. who.int/publications-detail/disability-considerations-during-the-covid-19- outbreak
  • 261. General-Medical-Council. Utils pour les personnes de 70 ans et plus et leurs proches (Tools for people aged 70 and over and caregivers). 2020. Available from: https://cmha.ca/blogs/tools-for-people-aged-70-and-over- andcaregivers
  • 262. General Medical Council. Joint statement: Supporting doctors in the event of a Covid-19 epidemic in the UK. 2020. Available from: gmc-uk.org/news/ news-archive/supporting-doctors-in-the-event-of-a-covid19-epidemic-inthe- uk
  • 263. Craig J, Patterson V. Introduction to the practice of telemedicine. J Telemed Telecare 2005;11:3-9.
  • 264. Ranschaert ER, Binkhuysen FH. Erratum to: European Teleradiology now and in the future: results of an online survey. 2013;4:399.
  • 265. Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: A systematic review of reviews. Int J Med Inform 2010;79:736-771.
  • 266. Vo A, Shore J, Waugh M, et al. Meaningful use: a national framework for integrated telemedicine. Telemed J E Health 2015;21:355-363.
  • 267. Kamphof I. A Modest Art: Securing Privacy in Technologically Mediated Homecare. Found Sci 2017;22:411-419.
  • 268. American Academy of Neurology (AAN). TELENEUROLOGY AND COVID-19. 2020. Available from: https://www.aan.com/tools-andresources/ practicing-neurologists-administrators/telemedicine-and-remotecare/
  • 269. Awadallah M, Janssen F, Körber B, Breuer L, Scibor M, Handschu R. Telemedicine in General Neurology: Interrater Reliability of Clinical Neurological Examination Via Audio-Visual Telemedicine. Eur Neuro 2018;80:289-294.
  • 270. Timpano F, Bonanno L, Bramanti A, et al. Tele-Health and neurology: what is possible? Neurol Sci 2013;34:2263-2270.
  • 271. Ciemins EL, Holloway B, Coon PJ, McClosky-Armstrong T, Min SJ. Telemedicine and the mini-mental state examination: assessment from a distance. Telemed J E Health 2009;15:476-478.
  • 272. Hatcher-Martin JM, Adams JL, Anderson ER, et al. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update. Neurology 2020;94:30-38.
  • 273. Stubberud A, Linde M. Digital Technology and Mobile Health in Behavioral Migraine Therapy: a Narrative Review. Curr Pain Headache Rep 2018;22:66.
  • 274. Moyle W. The promise of technology in the future of dementia care. Nat Rev Neurol 2019;15:353-359.
  • 275. Grosch MC, Weiner MF, Hynan LS, Shore J, Cullum CM. Video teleconference-based neurocognitive screening in geropsychiatry. Psychiatry Res 2015;225:734-735.
  • 276. Mantani A, Kato T, Furukawa TA, et al. Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial. J Med Internet Res 2017;19:e373.
  • 277. Ben-Pazi H, Browne P, Chan P, et al. The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach. Curr Neurol Neurosci 2018;18:26.
  • 278. Rasmusson KA, Hartshorn JC. A comparison of epilepsy patients in a traditional ambulatory clinic and a telemedicine clinic. Epilepsia 2005;46:767-770.
  • 279. Solenski NJ. Telestroke. Neuroimaging Clin N Am 2018;28: 551-563.
  • 280. Bagot KL, Cadilhac DA, Bladin CF. Recommendation for an internationally agreed minimum data set for teleneurology. Nat Rev Neurol 2018;14:687.
  • 281. T.C. Sağlık Bakanlığı. Teletıp Sistemi. 2020. Available from: https://teletip. saglik.gov.tr/
  • 282. Ege Üniversitesi Haber Ajansı. 2020. Available from: https://egeajans.ege. edu.tr/?p=13708
  • 283. TITCK-Türkiye İlaç ve Tıbbi Cihaz Kurumu. 2020. Available from: https:// www.titck.gov.tr/faaliyetalanlari/ilac/klinik-arastirmalar
  • 284. Alzforum. Coronavirus Takes Its Toll on Alzheimer’s Clinical Studies. 2020. Available from: https://www.alzforum.org/news/community-news/ coronavirus-takes-its-toll-alzheimers-clinical-studies
  • 285. FDA. Clinical Trial Conduct During the COVID-19 Pandemic. Available from: https://www.fda.gov/drugs/coronavirus-covid-19-drugs/clinical-trialconduct- during-covid-19-pandemic
  • 286. Ledford H. Coronavirus shuts down trials of drugs for multiple other diseases. Nature 2020; 580:15-16
  • 287. Clinical Trials Arena. Covid-19: Healthcare daily update - two thirds of cases may be undiagnosed - pandemic impacting on clinical trials in neurology. 2020. Available from: https://www.clinicaltrialsarena.com/special-focus/ covid-19/covid-19-healthcare-daily-update-two-thirds-of-cases-may-beundiagnosed- pandemic-impacting-on-clinical-trials-in-neurology/
  • 288. Ema. Guidance on the Management of Clinical Trials During the COVID-19 (coronavirus) Pandemic. Available from: https://ec.europa.eu/health/sites/ health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf
  • 289. TITCK-Türkiye-İlaç-ve-Tıbbi-Cihaz-Kurumu. COVID-19 Pandemisi Nedeniyle Klinik Araştırmalarda Alınacak Tedbirler 2020. Available from:https://titck.gov.tr/storage/Archive/2020/announcement COVID19KATedbirlerSSS_1cf892e0- 737f-42a5-b6ba-06949429be3e.pdf
  • 290. Berenbaum MR. PNAS and the pandemic. PNAS 2020;117:9650-9651.
  • 291. Elsevier. Special Issue on COVID-19. Available from: https://www.journals. elsevier.com/finance-research-letters/call-for-papers/special-issue-oncovid- 19
  • 292. Bedford J, Enria D, Giesecke J, et al. COVID-19: towards controlling of a pandemic. Lancet 2020; 395: 1015-1018.
  • 293. Bhidayasiri R, Virameteekul S, Kim JM, Pal PK, Chung SJ. COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care. J Mov Disord 2020;13:105-114.
  • 294. Dafer RM, Osteraas ND, Biller J. Acute Stroke Care in the Coronavirus Disease 2019 Pandemic. J Stroke Cerebrovasc Dis 2020;29:104881.
  • 295. Sellner J, Taba P, Öztürk S, Helbok R. The need for neurologists in the care of COVID-19 patients. Eur J Neurol 2020. DOI:10.1111/ene.14257
  • 296. Helbok R, Öztürk S. COVID-19 Statement of the EAN Scientific Panel Neurocritical care April 16, 2020. https://www.eanpages.org/2020/04/16/ covid-19-statement-of-the-ean-scientific-panel-neurocritical-care/
APA Acar T, Acıman Demirel e, Afsar N, Akcali A, Akman-Demir G, Alagoz A, Mengi T, Arsava E, Ayta S, Bebek N, bilgic b, Boz C, Cakar A, Celebisoy N, Çevik M, Delen F, Durmus H, Ekmekci H, Elmali A, ERDINC O, Erdoğan F, EREN F, ergün u, parman y, Gumus H, ILHAN ALGIN D, Karabudak R, karadaş ö, Kayim Yildiz O, KOÇ E, Özbabalık adapınar D, Ozdemir A, Ozturk S, Sagduyu Kocaman A, Sahin S, Saka Topçuoğlu E, SENER H, TEZER FILIK F, TOGROL R, BORA TOKCAER A, TOPCUOGLU M, Tuncer E, Uca A, Uluc K, Yaka E, Yon M (2020). Nörolojik Bakış Açısından COVID-19. , 58 - 108. 10.4274/tnd.2020.73669
Chicago Acar Türkan,Acıman Demirel esra,Afsar Nazire,Akcali Aylin,Akman-Demir Gulsen,Alagoz Aybala Neslihan,Mengi Tuğçe,Arsava Ethem Murat,Ayta Semih,Bebek Nerses,bilgic basar,Boz Cavit,Cakar Arman,Celebisoy Nese,Çevik Mehmet uğur,Delen Firuze,Durmus Hacer,Ekmekci Hakan,Elmali Ayse Deniz,ERDINC OGUZ,Erdoğan Füsun Ferda,EREN Fettah,ergün ufuk,parman yesim,Gumus Haluk,ILHAN ALGIN DEMET,Karabudak Rana,karadaş ömer,Kayim Yildiz Ozlem,KOÇ EMINE RABIA,Özbabalık adapınar Demet,Ozdemir Atilla Ozcan,Ozturk Serefnur,Sagduyu Kocaman Ayse,Sahin Sevki,Saka Topçuoğlu Esen,SENER H. Ozden,TEZER FILIK F. IRSEL,TOGROL R. Erdem,BORA TOKCAER Ayse,TOPCUOGLU MEHMET,Tuncer Emine Neşe,Uca Ali Ulvi,Uluc Kayihan,Yaka Erdem,Yon Mehmet Ilker Nörolojik Bakış Açısından COVID-19. (2020): 58 - 108. 10.4274/tnd.2020.73669
MLA Acar Türkan,Acıman Demirel esra,Afsar Nazire,Akcali Aylin,Akman-Demir Gulsen,Alagoz Aybala Neslihan,Mengi Tuğçe,Arsava Ethem Murat,Ayta Semih,Bebek Nerses,bilgic basar,Boz Cavit,Cakar Arman,Celebisoy Nese,Çevik Mehmet uğur,Delen Firuze,Durmus Hacer,Ekmekci Hakan,Elmali Ayse Deniz,ERDINC OGUZ,Erdoğan Füsun Ferda,EREN Fettah,ergün ufuk,parman yesim,Gumus Haluk,ILHAN ALGIN DEMET,Karabudak Rana,karadaş ömer,Kayim Yildiz Ozlem,KOÇ EMINE RABIA,Özbabalık adapınar Demet,Ozdemir Atilla Ozcan,Ozturk Serefnur,Sagduyu Kocaman Ayse,Sahin Sevki,Saka Topçuoğlu Esen,SENER H. Ozden,TEZER FILIK F. IRSEL,TOGROL R. Erdem,BORA TOKCAER Ayse,TOPCUOGLU MEHMET,Tuncer Emine Neşe,Uca Ali Ulvi,Uluc Kayihan,Yaka Erdem,Yon Mehmet Ilker Nörolojik Bakış Açısından COVID-19. , 2020, ss.58 - 108. 10.4274/tnd.2020.73669
AMA Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M Nörolojik Bakış Açısından COVID-19. . 2020; 58 - 108. 10.4274/tnd.2020.73669
Vancouver Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M Nörolojik Bakış Açısından COVID-19. . 2020; 58 - 108. 10.4274/tnd.2020.73669
IEEE Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M "Nörolojik Bakış Açısından COVID-19." , ss.58 - 108, 2020. 10.4274/tnd.2020.73669
ISNAD Acar, Türkan vd. "Nörolojik Bakış Açısından COVID-19". (2020), 58-108. https://doi.org/10.4274/tnd.2020.73669
APA Acar T, Acıman Demirel e, Afsar N, Akcali A, Akman-Demir G, Alagoz A, Mengi T, Arsava E, Ayta S, Bebek N, bilgic b, Boz C, Cakar A, Celebisoy N, Çevik M, Delen F, Durmus H, Ekmekci H, Elmali A, ERDINC O, Erdoğan F, EREN F, ergün u, parman y, Gumus H, ILHAN ALGIN D, Karabudak R, karadaş ö, Kayim Yildiz O, KOÇ E, Özbabalık adapınar D, Ozdemir A, Ozturk S, Sagduyu Kocaman A, Sahin S, Saka Topçuoğlu E, SENER H, TEZER FILIK F, TOGROL R, BORA TOKCAER A, TOPCUOGLU M, Tuncer E, Uca A, Uluc K, Yaka E, Yon M (2020). Nörolojik Bakış Açısından COVID-19. Türk Nöroloji Dergisi, 26(2), 58 - 108. 10.4274/tnd.2020.73669
Chicago Acar Türkan,Acıman Demirel esra,Afsar Nazire,Akcali Aylin,Akman-Demir Gulsen,Alagoz Aybala Neslihan,Mengi Tuğçe,Arsava Ethem Murat,Ayta Semih,Bebek Nerses,bilgic basar,Boz Cavit,Cakar Arman,Celebisoy Nese,Çevik Mehmet uğur,Delen Firuze,Durmus Hacer,Ekmekci Hakan,Elmali Ayse Deniz,ERDINC OGUZ,Erdoğan Füsun Ferda,EREN Fettah,ergün ufuk,parman yesim,Gumus Haluk,ILHAN ALGIN DEMET,Karabudak Rana,karadaş ömer,Kayim Yildiz Ozlem,KOÇ EMINE RABIA,Özbabalık adapınar Demet,Ozdemir Atilla Ozcan,Ozturk Serefnur,Sagduyu Kocaman Ayse,Sahin Sevki,Saka Topçuoğlu Esen,SENER H. Ozden,TEZER FILIK F. IRSEL,TOGROL R. Erdem,BORA TOKCAER Ayse,TOPCUOGLU MEHMET,Tuncer Emine Neşe,Uca Ali Ulvi,Uluc Kayihan,Yaka Erdem,Yon Mehmet Ilker Nörolojik Bakış Açısından COVID-19. Türk Nöroloji Dergisi 26, no.2 (2020): 58 - 108. 10.4274/tnd.2020.73669
MLA Acar Türkan,Acıman Demirel esra,Afsar Nazire,Akcali Aylin,Akman-Demir Gulsen,Alagoz Aybala Neslihan,Mengi Tuğçe,Arsava Ethem Murat,Ayta Semih,Bebek Nerses,bilgic basar,Boz Cavit,Cakar Arman,Celebisoy Nese,Çevik Mehmet uğur,Delen Firuze,Durmus Hacer,Ekmekci Hakan,Elmali Ayse Deniz,ERDINC OGUZ,Erdoğan Füsun Ferda,EREN Fettah,ergün ufuk,parman yesim,Gumus Haluk,ILHAN ALGIN DEMET,Karabudak Rana,karadaş ömer,Kayim Yildiz Ozlem,KOÇ EMINE RABIA,Özbabalık adapınar Demet,Ozdemir Atilla Ozcan,Ozturk Serefnur,Sagduyu Kocaman Ayse,Sahin Sevki,Saka Topçuoğlu Esen,SENER H. Ozden,TEZER FILIK F. IRSEL,TOGROL R. Erdem,BORA TOKCAER Ayse,TOPCUOGLU MEHMET,Tuncer Emine Neşe,Uca Ali Ulvi,Uluc Kayihan,Yaka Erdem,Yon Mehmet Ilker Nörolojik Bakış Açısından COVID-19. Türk Nöroloji Dergisi, vol.26, no.2, 2020, ss.58 - 108. 10.4274/tnd.2020.73669
AMA Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M Nörolojik Bakış Açısından COVID-19. Türk Nöroloji Dergisi. 2020; 26(2): 58 - 108. 10.4274/tnd.2020.73669
Vancouver Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M Nörolojik Bakış Açısından COVID-19. Türk Nöroloji Dergisi. 2020; 26(2): 58 - 108. 10.4274/tnd.2020.73669
IEEE Acar T,Acıman Demirel e,Afsar N,Akcali A,Akman-Demir G,Alagoz A,Mengi T,Arsava E,Ayta S,Bebek N,bilgic b,Boz C,Cakar A,Celebisoy N,Çevik M,Delen F,Durmus H,Ekmekci H,Elmali A,ERDINC O,Erdoğan F,EREN F,ergün u,parman y,Gumus H,ILHAN ALGIN D,Karabudak R,karadaş ö,Kayim Yildiz O,KOÇ E,Özbabalık adapınar D,Ozdemir A,Ozturk S,Sagduyu Kocaman A,Sahin S,Saka Topçuoğlu E,SENER H,TEZER FILIK F,TOGROL R,BORA TOKCAER A,TOPCUOGLU M,Tuncer E,Uca A,Uluc K,Yaka E,Yon M "Nörolojik Bakış Açısından COVID-19." Türk Nöroloji Dergisi, 26, ss.58 - 108, 2020. 10.4274/tnd.2020.73669
ISNAD Acar, Türkan vd. "Nörolojik Bakış Açısından COVID-19". Türk Nöroloji Dergisi 26/2 (2020), 58-108. https://doi.org/10.4274/tnd.2020.73669